HIGHLIGHTS
- who: Paolo Sfriso from the University Pennsylvania, United States have published the research: Response to Interleukin-1 Inhibitors in 140 Italian Patients with Adult-Onset Still's Disease:A Multicentre Retrospective Observational Study, in the Journal: (JOURNAL)
- what: This study aimed to examine the use of IL-1-INH in a large number of Italian patients with AOSD, found to be refractory to other therapies. The main reason for treatment discontinuation was linked to the development of AEs (24/71 patients, 33.8%) followed by remission (sustained disappearance of all clinical and serological manifestations) in . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.